JP2020534320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020534320A5 JP2020534320A5 JP2020516620A JP2020516620A JP2020534320A5 JP 2020534320 A5 JP2020534320 A5 JP 2020534320A5 JP 2020516620 A JP2020516620 A JP 2020516620A JP 2020516620 A JP2020516620 A JP 2020516620A JP 2020534320 A5 JP2020534320 A5 JP 2020534320A5
- Authority
- JP
- Japan
- Prior art keywords
- avilateron
- pharmaceutical preparation
- preparation according
- present
- amorphous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023167274A JP2023182674A (ja) | 2017-09-22 | 2023-09-28 | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762562081P | 2017-09-22 | 2017-09-22 | |
| US62/562,081 | 2017-09-22 | ||
| PCT/US2018/051914 WO2019060525A1 (en) | 2017-09-22 | 2018-09-20 | PHARMACEUTICAL FORMULATIONS OF CYCLIC OLIGOMER AND ABIRATERONE AND METHODS OF FORMATION AND ADMINISTRATION THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023167274A Division JP2023182674A (ja) | 2017-09-22 | 2023-09-28 | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020534320A JP2020534320A (ja) | 2020-11-26 |
| JP2020534320A5 true JP2020534320A5 (https=) | 2021-10-28 |
Family
ID=65808544
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020516620A Pending JP2020534320A (ja) | 2017-09-22 | 2018-09-20 | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 |
| JP2023167274A Pending JP2023182674A (ja) | 2017-09-22 | 2023-09-28 | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023167274A Pending JP2023182674A (ja) | 2017-09-22 | 2023-09-28 | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20190091339A1 (https=) |
| EP (1) | EP3684371A4 (https=) |
| JP (2) | JP2020534320A (https=) |
| KR (1) | KR20200064993A (https=) |
| CN (1) | CN111107852A (https=) |
| AU (1) | AU2018335391A1 (https=) |
| CA (1) | CA3075095A1 (https=) |
| IL (1) | IL273125A (https=) |
| MA (1) | MA50189A (https=) |
| WO (1) | WO2019060525A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020240017A1 (en) * | 2019-03-18 | 2021-11-04 | AustinPx, LLC | Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof |
| CN110141556B (zh) * | 2019-06-24 | 2021-07-13 | 李建恒 | 一种阿比特龙包合物片剂及其制备方法 |
| WO2021086565A1 (en) * | 2019-11-01 | 2021-05-06 | Dispersol Technologies, Llc | Weakly basic drug and ionic polymer pharmaceutical formulations and methods of formation and administration thereof |
| CA3160834C (en) * | 2019-11-14 | 2024-06-11 | Suven Life Sciences Limited | Amorphous pharmaceutical compositions of abiraterone acetate |
| US20220401579A1 (en) * | 2019-11-30 | 2022-12-22 | Dispersol Technologies, Llc | Inclusion complexes of pharmaceuticals and cyclic oligomers |
| KR102363026B1 (ko) * | 2019-12-26 | 2022-02-16 | 보령제약 주식회사 | 아비라테론 아세테이트 또는 이의 약제학적으로 허용 가능한 염을 포함하는 전립선암 예방 또는 치료용 약학적 조성물 |
| CA3203975A1 (en) | 2020-12-03 | 2022-06-09 | Battelle Memorial Institute | Polymer nanoparticle and dna nanostructure compositions and methods for non-viral delivery |
| CA3216359A1 (en) | 2021-04-07 | 2022-10-13 | Battelle Memorial Institute | Rapid design, build, test, and learn technologies for identifying and using non-viral carriers |
| AU2024353375A1 (en) | 2023-09-29 | 2026-04-09 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| WO2025122954A1 (en) | 2023-12-08 | 2025-06-12 | Battelle Memorial Institute | Use of dna origami nanostructures for molecular information based data storage systems |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6073043B2 (ja) * | 2007-08-21 | 2017-02-01 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 医薬品適用のための熱−動力学的混合 |
| US9040080B2 (en) * | 2008-10-21 | 2015-05-26 | Southwest Research Institute | Processing of heat-sensitive active agents |
| CN103813794A (zh) * | 2011-07-18 | 2014-05-21 | 拓凯制药公司 | 用于治疗前列腺癌的新型组合物及方法 |
| HRP20191982T4 (hr) * | 2011-11-30 | 2023-01-06 | Astrazeneca Ab | Kombinacijsko liječenje raka |
| GB201207886D0 (en) * | 2012-05-04 | 2012-06-20 | Jagotec Ag | Improvements in or relating to organic compounds |
| WO2014009437A1 (en) * | 2012-07-11 | 2014-01-16 | Sandoz Ag | Oxidation stability of abiraterone acetate |
| US20140287039A1 (en) * | 2013-03-15 | 2014-09-25 | Iceutica Inc. | Abiraterone Acetate Formulation |
| WO2015032873A1 (en) * | 2013-09-06 | 2015-03-12 | Synthon B.V. | High-load pharmaceutical compositions comprising abiraterone acetate |
| WO2016051368A1 (en) * | 2014-10-01 | 2016-04-07 | Mylan Laboratories Ltd | Complex of amorphous empagliflozin and a cyclodextrin |
| WO2017037647A1 (en) * | 2015-09-02 | 2017-03-09 | Leiutis Pharmaceuticals Pvt Ltd | Stable pharmaceutical compositions of abiraterone |
-
2018
- 2018-09-20 WO PCT/US2018/051914 patent/WO2019060525A1/en not_active Ceased
- 2018-09-20 CN CN201880061714.XA patent/CN111107852A/zh active Pending
- 2018-09-20 US US16/136,413 patent/US20190091339A1/en not_active Abandoned
- 2018-09-20 KR KR1020207008684A patent/KR20200064993A/ko not_active Ceased
- 2018-09-20 AU AU2018335391A patent/AU2018335391A1/en not_active Abandoned
- 2018-09-20 JP JP2020516620A patent/JP2020534320A/ja active Pending
- 2018-09-20 MA MA050189A patent/MA50189A/fr unknown
- 2018-09-20 CA CA3075095A patent/CA3075095A1/en active Pending
- 2018-09-20 EP EP18858759.6A patent/EP3684371A4/en not_active Withdrawn
-
2020
- 2020-03-08 IL IL273125A patent/IL273125A/en unknown
-
2023
- 2023-09-28 JP JP2023167274A patent/JP2023182674A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020534320A5 (https=) | ||
| JP2023182674A (ja) | アビラテロン環状オリゴマー薬学的製剤ならびにその形成法および投与法 | |
| JP6522853B2 (ja) | Ｓｏｍｃｌ−９１１２固体分散体、その製造方法およびそれを含むｓｏｍｃｌ−９１１２固体製剤 | |
| JP6697473B2 (ja) | 酢酸アビラテロンの複合体、その製造のための方法、およびそれらを含有する医薬組成物 | |
| CN101664411A (zh) | 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂 | |
| TW200304379A (en) | Pharmaceutical composition | |
| CN109153735A (zh) | 基于环糊精的聚合物、其方法、组合物和应用 | |
| WO2017133662A1 (zh) | 一种紫杉醇药物组合物及其药物制剂、制备方法和用途 | |
| CN108495620A (zh) | 包含苯基氨基嘧啶衍生物的药物组合物 | |
| JP2022525425A5 (https=) | ||
| JPWO2017195804A1 (ja) | １５β−ヒドロキシ−酢酸オサテロンの結晶多形 | |
| TW202028194A (zh) | 呋喹替尼製劑及其應用 | |
| CN103936808A (zh) | 17β雌二醇的异烟酰胺共结晶及其制备方法和应用 | |
| CN103951725A (zh) | 17β雌二醇的哌嗪共结晶及其制备方法和应用 | |
| CN108272754A (zh) | 一种抗癌药物固体分散体组合物及其制备方法 | |
| US20220362264A1 (en) | Abiraterone-cyclic oligomer pharmaceutical formulations and methods of formation and administration thereof | |
| JP2020536126A (ja) | 経口ベンダムスチン製剤 | |
| CN115702897A (zh) | 一种包含沃替西汀前药或其盐的药物组合物 | |
| TW201516023A (zh) | 使用噴霧乾燥法之Ｄ－甘露醇α型結晶之選擇性製造方法 | |
| EP2997046B1 (en) | Cellulose ethers esterified with dicarboxylic acids | |
| WO2010010367A1 (en) | Solid pharmaceutical composition comprising exemestane | |
| CN113924145A (zh) | 痛风或高尿酸血症的治疗药 | |
| WO2021064580A1 (en) | Controlled release injectable ondansetron formulations | |
| WO2019130194A1 (en) | Novel drug products of picropodophyllin |